Mifepristone: less obvious adverse effects.
作者信息
Rudd G
机构信息
Christian Medical and Dental Associations, Bristol, TN, USA.
出版信息
Ann Pharmacother. 2001 Mar;35(3):381-2. doi: 10.1345/aph.10410.
PMID:11261540
Abstract
摘要
相似文献
1
Mifepristone: less obvious adverse effects.
Ann Pharmacother. 2001 Mar;35(3):381-2. doi: 10.1345/aph.10410.
2
Mifepristone--a boom or a bust?米非司酮——是福星还是灾星？
Ann Pharmacother. 2001 Mar;35(3):376-80. doi: 10.1345/aph.10389.
3
Aligning mifepristone regulation with evidence: driving policy change using 15 years of excellent safety data.使米非司酮监管符合证据：利用15年的出色安全数据推动政策变革。
Contraception. 2015 Sep;92(3):179-81. doi: 10.1016/j.contraception.2015.06.016. Epub 2015 Jun 18.
4
Abortifacient drug approved for restricted, physician-only distribution.堕胎药获批，仅限医生处方使用。
Am J Health Syst Pharm. 2000 Nov 1;57(21):1940. doi: 10.1093/ajhp/57.21.1940a.
5
Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.评论：米非司酮作为堕胎药使用相关严重不良事件的分析。
Ann Pharmacother. 2006 Apr;40(4):785-6; author reply 786. doi: 10.1345/aph.1G481c. Epub 2006 Mar 28.
6
Fatal infections associated with mifepristone-induced abortion.
N Engl J Med. 2005 Dec 1;353(22):2317-8. doi: 10.1056/NEJMp058260.
7
Comment: analysis of severe adverse events related to the use of mifepristone as an abortifacient.
Ann Pharmacother. 2006 Jun;40(6):1215-6; author reply 1216-7. doi: 10.1345/aph.1G481d. Epub 2006 May 30.
8
Rupture in an unscarred uterus during second trimester pregnancy termination with mifepristone and misoprostol.在孕中期使用米非司酮和米索前列醇终止妊娠时未瘢痕化子宫发生破裂。
Int J Gynaecol Obstet. 2004 Oct;87(1):42-3. doi: 10.1016/j.ijgo.2004.05.019.
9
Abortion pill gets FDA approval.
Circulation. 2000 Oct 10;102(15):E9030-1.
10
New warning for mifepristone and misoprostol.米非司酮和米索前列醇的新警告。
Lancet. 2005;366(9483):344.
Zotero 插件